News for Healthier Living

Roswell Park-Led Team Proposes CDK2 Enzyme as New Target for Cancer Therapy

A new study published in the journal Nature Communications, led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, of Roswell Park, highlights the therapeutic impact of CDK2 inhibitors as treatment for cancers including some breast and pancreatic tumors.

February 14, 2025


February 21 2025

February 20 2025

February 19 2025

February 18 2025

February 17 2025

February 16 2025

February 15 2025

February 14 2025

February 13 2025

February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025